Physician profile
James Kiely
NPI 1205911096
$592.34
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $592.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $101.76 | 2019 | |
| Supernus Pharmaceuticals, INC. | $73.75 | 2019 | |
| Biogen, INC. | $73.26 | 2019 | |
| Novartis Pharmaceuticals Corporation | $40.73 | 2019 | |
| Amgen INC. | $40.61 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $36.06 | 2019 | |
| Ucb, INC. | $26.08 | 2019 | |
| Bausch Health US, LLC | $22.42 | 2019 | |
| Abbvie INC. | $21.86 | 2019 | |
| Neurocrine Biosciences, INC. | $21.03 | 2019 | |
| Allergan, INC. | $19.53 | 2019 | |
| Lundbeck LLC | $19.35 | 2019 | |
| Acadia Pharmaceuticals INC | $19.14 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $17.74 | 2019 | |
| Promius Pharma LLC | $17.31 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $14.66 | 2019 | |
| Mdd US Operations, LLC | $14.56 | 2019 | |
| Emd Serono, INC. | $12.49 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Kiely listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.